PSA measurement following prostatectomy: an unexpected error.
An unexpected and exceptional observation was made during the biological follow-up of a patient who had undergone a radical prostatectomy for a prostate adenocarcinoma. A residual PSA level was first considered as a reliable marker of relapse. Certain limits are highlighted concerning the reliability of the PSA assay, which must be interpreted along with all the other prognostic information on the tumor and possibly verified using other biological techniques.
Descotes
Jean-Luc
JL
Service de Chirurgie Urologique et de Transplantation Rénale, CHU de Grenoble, 38043 Grenoble 9, France.
Legeais
Didier
D
Gauchez
Anne-Sophie
AS
Long
Jean-Alexandre
JA
Rambeaud
Jean-Jacques
JJ
D000230:Adenocarcinoma / Q000097:blood* / Q000601:surgery; D000368:Aged; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000601:surgery
D017430:Prostate-Specific Antigen